Samsung Biologics Co Ltd (207940)

Seoul
Currency in KRW
991,000
-49,000(-4.71%)
Closed·
207940 Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
Unusual trading volume
Fair Value
Day's Range
989,0001,042,000
52 wk Range
721,0001,209,000
Key Statistics
Edit
Bid/Ask
991,000.00 / 992,000.00
Prev. Close
1,040,000
Open
1,041,000
Day's Range
989,000-1,042,000
52 wk Range
721,000-1,209,000
Volume
144.76K
Average Volume (3m)
67.79K
1-Year Change
27.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
207940 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,313,375
Upside
+32.53%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Samsung Biologics Company Profile

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Employees
4770

Compare 207940 to Peers and Sector

Metrics to compare
207940
Peers
Sector
Relationship
P/E Ratio
65.6x15.6x−0.5x
PEG Ratio
2.481.050.00
Price/Book
6.5x1.5x2.6x
Price / LTM Sales
15.6x2.4x2.9x
Upside (Analyst Target)
31.2%41.0%53.4%
Fair Value Upside
Unlock10.4%10.2%Unlock

Analyst Ratings

23 Buy
1 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,313,375
(+32.53% Upside)

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
5,277.21 / 3,754.74
Revenue / Forecast
1.2983T / 1.20849T
EPS Revisions
Last 90 days

People Also Watch

151,800
068270
-3.92%
321,500
373220
+1.10%
263,000
005490
+1.74%
67,300
035900
-3.17%
92,600
096770
+1.98%

FAQ

What Is the Samsung Biologics (207940) Stock Price Today?

The Samsung Biologics stock price today is 991,000.00

What Stock Exchange Does Samsung Biologics Trade On?

Samsung Biologics is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Samsung Biologics?

The stock symbol for Samsung Biologics is "207940."

What Is the Samsung Biologics Market Cap?

As of today, Samsung Biologics market cap is 74.02T.

What Is Samsung Biologics's Earnings Per Share (TTM)?

The Samsung Biologics EPS (TTM) is 15,220.67.

When Is the Next Samsung Biologics Earnings Date?

Samsung Biologics will release its next earnings report on 22 Jul 2025.

From a Technical Analysis Perspective, Is 207940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.